1. AHRO : Austin Health Research Online

Sagun Parakh

View Statistics Email Alert RSS Feed
 Claim profile

Profile

Loading... 2 0 20 0 false
Credit Name
Sagun Parakh
Full Name
Parakh, Sagun
 
Department
 
ORCID
Loading... 3 0 20 0 false

Publications

Results 41-53 of 53 (Search time: 0.009 seconds).

Publication YearTitleAuthor(s)
412018Delayed Autoimmune Toxicity Occurring Several Months After Cessation of Anti-PD-1 Therapy.Parakh, Sagun ; Cebon, Jonathan S ; Klein, Oliver 
42Aug-2017Late presentation of generalised bullous pemphigoid-like reaction in a patient treated with pembrolizumab for metastatic melanoma.Parakh, Sagun ; Nguyen, Rebecca; Opie, Jacinta M; Andrews, Miles C
436-Jul-2017Evolution of anti-HER2 therapies for cancer treatmentParakh, Sagun ; Gan, Hui K ; Parslow, Adam C; Burvenich, Ingrid JG; Burgess, Antony W; Scott, Andrew M 
44Jun-2017Survival and functional outcomes of patients with metastatic solid organ cancer admitted to the intensive care unit of a tertiary centreHa, Francis J; Weickhardt, Andrew J ; Parakh, Sagun ; Vincent, Andrew D; Glassford, Neil J; Warrillow, Stephen J ; Jones, Daryl A 
45Jun-2017Efficacy of anti-PD-1 therapy in patients with melanoma brain metastasesParakh, Sagun ; Park, John J; Mendis, Shehara; Rai, Rajat; Xu, Wen; Lo, Serigne; Drummond, Martin; Rowe, Catherine; Wong, Annie; McArthur, Grant; Haydon, Andrew; Andrews, Miles C; Cebon, Jonathan S ; Guminski, Alex; Kefford, Richard F; Long, Georgina V; Menzies, Alexander M; Klein, Oliver ; Carlino, Matteo S
4611-Apr-2017Reply to 'Comment on 'Efficacy and toxicity of treatment with the anti-CTLA-4 antibody ipilimumab in patients with metastatic melanoma after prior anti-PD-1 therapy''.Bowyer, Samantha; Prithviraj, Prashanth; Lorigan, Paul; Larkin, James; McArthur, Grant; Atkinson, Victoria; Millward, Michael; Khou, Muoi; Diem, Stefan; Ramanujam, Sangeetha; Kong, Ben; Liniker, Elizabeth; Guminski, Alexander; Parente, Phillip; Andrews, Miles C; Parakh, Sagun ; Cebon, Jonathan S ; Long, Georgina V; Carlino, Matteo S; Klein, Oliver 
47Nov-2016Temozolomide-associated liver fibrosisParakh, Sagun ; Hamid, Anis A; Cher, Lawrence M ; Gan, Hui K 
4811-Jul-2016Antibody-Drug Conjugates for Cancer Therapy.Parslow, Adam C; Parakh, Sagun ; Lee, Fook-Thean; Gan, Hui K ; Scott, Andrew M 
49Jun-2016Molecular Imaging and Quantitation of EphA2 Expression in Xenograft Models with 89Zr-DS-8895a.Burvenich, Ingrid J G; Parakh, Sagun ; Gan, Hui K ; Lee, Fook-Thean; Guo, Nancy; Rigopoulos, Angela; Lee, Sze-Ting; Gong, Sylvia; O'Keefe, Graeme J; Tochon-Danguy, Henri; Kotsuma, Masakatsu; Hasegawa, Jun; Senaldi, Giorgio; Scott, Andrew M 
5010-May-2016Efficacy and toxicity of treatment with the anti-CTLA-4 antibody ipilimumab in patients with metastatic melanoma after prior anti-PD-1 therapy.Bowyer, S; Prithviraj, Prashanth; Lorigan, P; Larkin, J; McArthur, G; Atkinson, V; Millward, M; Khou, M; Diem, S; Ramanujam, S; Kong, B; Liniker, E; Guminski, A; Parente, P; Andrews, M C; Parakh, S ; Cebon, Jonathan S ; Long, G V; Carlino, M S; Klein, O 
51Feb-2016Recurrent glioblastoma: current patterns of care in an Australian populationParakh, Sagun ; Thursfield, Vicky; Cher, Lawrence M ; Dally, Michael; Drummond, Katharine J; Murphy, Michael; Rosenthal, Mark A; Gan, Hui K 
522016Antibody-mediated delivery of therapeutics for cancer therapyParakh, Sagun ; Parslow, Adam C; Gan, Hui K ; Scott, Andrew M 
5310-Nov-2014Response to MAPK pathway inhibitors in BRAF V600M-mutated metastatic melanoma.Parakh, S ; Murphy, C; Lau, D ; Cebon, Jonathan S ; Andrews, Miles C